BLOOD PRESSURE DRUG
Zydus Lifesciences gets tentative approval from USFDA for BP lowering drug
Zydus Lifesciences announced on Thursday that it has received tentative approval from the US Food and Drug Administration (USFDA) to market its generic Azilsartan Medoxomil tablets, which are used to treat high blood pressure. The USFDA's tentative approval covers Azilsartan Medoxomil tablets in strengths of 40 mg and 80 mg.
Ozempic frenzy lures rich Indians to brave the gray market
People are going to great lengths to obtain popular weight-loss drugs. They are stashing injectables in their carry-on luggage, buying counterfeit formulas online, and importing boxes from Europe. The treatments have sparked extensive media coverage, fueling a high demand. According to Goldman Sachs Research, the anti-obesity medication market could hit $100 billion by 2030. In contrast, Indians have largely been observers in this global frenzy over the new weight-loss solutions.
Uphill Battle: Navigating the Complexities of Diabetes Management
Managing type 2 diabetes involves crucial lifestyle changes for blood sugar control, mental health support, weight management, nutrition therapy, stress management, physical activity, and glucose regulation.
Heatwave ignites surge in chronic therapy demand
Rising temperatures across various regions of India are driving increased demand for medications aimed at managing chronic conditions. This includes prescriptions for high blood pressure (antihypertensives), cholesterol (lipid-lowering drugs), and blood clotting (platelet aggregation inhibitors).
Glenmark recalls 6,528 bottles of blood pressure drug in US
As per the USFDA, a Class II recall is initiated in a situation in which the use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.
7 pharma firms facing probe for poor quality drugs funded parties through electoral bonds: Congress
Congress alleges seven pharmaceutical companies under scrutiny for producing substandard drugs donated Rs 1,000 crore to political parties via electoral bonds. Jairam Ramesh accuses government of "underhand deals," implying quid pro quo. Companies investigated for cough syrups, Remdesivir. Concerns raised over integrity of drug regulation.
- Go To Page 1
SC asks Patanjali's Baba Ramdev, Acharya Balkrishna to appear in-person for next hearing in misleading ads case
On February 27, the SC had expressed displeasure over Patanjali Ayurved continuing to publish false and misleading advertisements on medicinal cures despite giving an undertaking that it wouldn’t do so. It had issued notices to the company and Balkrishna asking them as to why contempt proceedings should not be initiated against them.
When do you need a cholesterol test? Foods that can improve your numbers
. Monitoring and managing cholesterol is crucial for heart health. Understanding when to test and interpret results can be overwhelming. Expert advice sheds light on cholesterol testing and strategies for control, vital for preventing heart disease and related complications.
Samsung gets go-ahead for BP/ECG readings on smartwatches
Samsung has received approval to enable blood pressure measurement and ECG readings on its smartwatches, bringing them on par with the Apple Watch in terms of health monitoring. This move is expected to help Samsung corner market-share in the premium wearables segment and clear existing inventory.
What other health conditions might weight-loss drugs treat?
New data suggests that semaglutide may also cut the risk of stroke or heart attack, and may delay the progression of kidney disease in diabetes patients.
Pakistan: Severe shortage of life-saving drugs in Karachi worries patients, citizens
Karachi in Pakistan is facing a severe shortage of essential medicines, including life-saving drugs, causing concern for patients and citizens. The Drug Regulatory Authority of Pakistan (DRAP) launched a crackdown last month against an artificial shortage of life-saving medicines, but the illegal sale of essential medicines continues.
Maker of Wegovy, Ozempic showers money on US obesity doctors
Novo Nordisk, a Danish pharmaceutical company renowned for its diabetes medicines, is now positioning itself as the world's leading weight-loss company. The company aims to target the global population of 764 million people with obesity, with the United States being its most lucrative market. In the U.S., where over two-thirds of adults are either overweight or obese, Novo charges customers $1,300 per month for the weekly injection of Wegovy.
From high blood pressure to poor heart health, the dangers of not getting ample sleep
Lack of sleep may even create memory problems and in later age, dementia.
Patients with high blood pressure double to 130 crore: WHO's first-ever report details devastating impact of hypertension
The World Health Organization (WHO) has released its first-ever report on hypertension, highlighting the need to address this silent killer. It is estimated that 4 out of 5 people with high blood pressure are not adequately treated. However, if countries can improve coverage, it is possible to avert 76 million deaths between 2023 and 2050. Hypertension affects 1 in 3 adults globally and can lead to various health problems if left untreated. Lifestyle changes, such as a healthier diet and increased physical activity, can help lower blood pressure, along with medication if necessary.
Price cap on concentrators, five other medical devices extended
In a recent meeting held in the NPPA, the drug pricing regulator "deliberated upon the matter and directed that the MRPs of five medical devices namely pulse oximeter, blood pressure monitoring machine, nebulizer, digital thermometer, glucometer shall continue to be monitored as per para 20(1) of DPCO 2013," said the minutes of the meeting.
World Blood Donor Day: Stick to low-fat meal 4 hrs before donating; skip if you have consumed alcohol the previous day
India is facing a huge blood shortage, with a demand and supply gap of 2.5 donations per 1,000 eligible persons, according to a recent study. Blood donation can save lives and improve the health of donors; it replenishes blood, reduces blood viscosity, prevents cardiovascular diseases, and releases happy hormones.
Blood Donation: Who can donate, who can't, and what are the rules for blood donation?
Blood donation is a selfless act that can make a profound difference in the lives of others. Understanding the criteria for blood donation, including who can donate and who can't, is crucial for both donors and recipients. By adhering to the rules and regulations surrounding blood donation, individuals can play an active role in saving lives and improving healthcare systems worldwide.
Obesity speeds up loss of immunity from Covid vaccines, increases risk of severe infection, shows new research
Several studies have suggested that following Covid vaccination, antibody levels may be lower in people with obesity than in the general population.
Granules gets USFDA nod to market generic medication to treat high blood pressure
The Hyderabad-based company's product is bioequivalent to the Organon LLC's Cozaar tablets.
12 Best BP Monitoring Machines in India for Easy Health Check-Ups at Home
Finding a reliable and accurate blood pressure monitor that makes at-home check-ups quick might be difficult, given the vast selection of BP monitoring machines available in India. To make your search for the best blood pressure monitoring systems, we have compiled our picks for 12 of the best BP monitoring machines in India. Read on to find more.
Sun Pharma recalls over 34k bottles of generic drug in US due to manufacturing issues
Princeton (New Jersey) based Sun Pharmaceutical Inc is recalling the affected lot due to "Failed Impurity (Deacetyl Diltiazem Hydrochloride) specification during stability testing and failed dissolution testing at FDA laboratory." The Mumbai-based drug major had produced the lot at its Halol-based manufacturing facility in Gujarat. The affected lot was later distributed in the market by its US-based unit.
Glenmark Pharma gets USFDA nod for generic drug
The approval granted by the US Food & Drug Administration (USFDA) is for bicardipine hydrochloride capsules of strengths 20 mg and 30 mg, Glenmark said in a statement.
Aurobindo units recall products in US market for manufacturing issues
The affected lot of the medication, which is used to treat high blood pressure, has been manufactured in India and marketed in the US market by Aurobindo Pharma USA, Inc. As per the USFDA, the company is recalling the affected lot due to "Current good manufacturing practices CGMP deviations: Detection of N-Nitroso-quinapril impurity above the acceptable daily intake limit."
Zydus gets USFDA nod to market generic blood pressure lowering drug
Norepinephrine Bitartrate is indicated for restoration of blood pressure in adult patients with acute hypotensive state. The drug will be manufactured at the group's topical injectable manufacturing facility at Jarod, Gujarat, Zydus Lifesciences said.
Strides Pharma recalls over 6 lakh bottles of blood pressure treatment tablets in US
As per the latest enforcement report by the US Food and Drug Administration (USFDA), the company, which is a unit of Bengaluru-headquartered Strides Pharma Science, is recalling 6,78,829 bottles of the blood pressure lowering drug in the US market.
How high blood pressure can cause damage to your health
High blood pressure or Hypertension affects more than 30 per cent of the adult population worldwide, which is more than one billion people around the world.
Pfizer recalls Accuretic, a generic drug, due to presence of nitrosamine that causes cancer
After discovering nitrosamine impurities, Pfizer has recalled the blood pressure drug Accuretic, among others. Studies have linked nitrosamine to a variety of cancers after repeated exposure to high levels for long periods of time.
Dr Reddy's launches drug to treat high blood pressure, heart failure in US market
Citing IQVIA Health data, the company said the Diovan brand and generic market had US sales of approximately USD 150 million for the most recent 12 months ended October 2021, it added.
Alembic gets USFDA nod for generic hypertension treatment drug
Alembic's product is the generic equivalent to the reference listed drug product (RLD) Uptravi.
Load More
